Adamas Pharmaceuticals

+$0.06 (+0.74%) As of 10:55 PM UTC pre-market

Why Robinhood?

You can watch ADMS and buy or sell other stocks, options, and ETFs commission-free!

About ADMS

Adamas Pharmaceuticals, Inc. engages in the development and commercialization of controlled release combination therapeutics to treat healthcare problems, primarily in the areas of infectious diseases and central nervous system disorders. It also develops novel extended release and combination products for symptomatic treatment of dementia.

CEO
Neil F. McFarlane
Employees
—
Headquarters
Emeryville, California
Founded
2000

ADMS Key Statistics

Market cap
375.58M
Price-Earnings ratio
—
Dividend yield
—
Average volume
964.73K
High today
—
Low today
—
Open price
—
Volume
0.00
52 Week high
$9.15
52 Week low
$4.02

ADMS Earnings

-$0.64
-$0.43
-$0.21
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 8, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure